Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells

Abstract Background Cisplatin (CDDP) significantly prolongs survival in various cancers, but many patients also develop resistance that results in treatment failure. Thus, this study aimed to elucidate the underlying mechanisms by which ovarian cancer cells acquire CDDP resistance. Methods We evalua...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jing Guo, Kiyotoshi Satoh, Sho Tabata, Masaru Mori, Masaru Tomita, Tomoyoshi Soga
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2021-02-01
Col·lecció:	BMC Cancer
Matèries:	Ovarian cancer Cisplatin resistance Glutamine synthetase Metabolome CE-TOFMS
Accés en línia:	https://doi.org/10.1186/s12885-021-07879-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!